Literature DB >> 21495584

Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures.

H Qureshi1, K M Bile, R Jooma, S E Alam, H U R Afridi.   

Abstract

A prevalence survey on hepatitis B and C infections was carried out to obtain national estimates and assess epidemiological dynamics and underlying risk factors. Overall prevalence of hepatitis B surface antigen (HBsAg) and anti-hepatitis C virus (HCV) of 2.5% and 4.8%, respectively, reflected a combined infection rate of 7.6% in the general population, consistent with an ongoing high burden of chronic liver disease (CLD). There was significant association of these viral infections with a range of risk factors led by reuse of syringes. These findings validate currently implemented strategies by the national programme for the control of hepatitis viral infections, including universal vaccination of newborns and high-risk groups, support of auto-disable syringes, promotion of infection control and patient safety, public health education, and management of needy CLD patients as a poverty-reduction health intervention.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21495584

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  55 in total

Review 1.  Towards safe injection practices for prevention of hepatitis C transmission in South Asia: Challenges and progress.

Authors:  Naveed Zafar Janjua; Zahid Ahmad Butt; Bushra Mahmood; Arshad Altaf
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 2.  Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.

Authors:  Shiv K Sarin; Manoj Kumar; Mohammed Eslam; Jacob George; Mamun Al Mahtab; Sheikh M Fazle Akbar; Jidong Jia; Qiuju Tian; Rakesh Aggarwal; David H Muljono; Masao Omata; Yoshihiko Ooka; Kwang-Hyub Han; Hye Won Lee; Wasim Jafri; Amna S Butt; Chern H Chong; Seng G Lim; Raoh-Fang Pwu; Ding-Shinn Chen
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-12-15

Review 3.  Prevalence and current therapy in chronic liver disorders.

Authors:  Muhammad Daniyal; Muhammad Akram; Rida Zainab; Naveed Munir; Aamir Sharif; Syed Muhammad Ali Shah; Bin Liu; Wei Wang
Journal:  Inflammopharmacology       Date:  2019-02-08       Impact factor: 4.473

4.  Prevalence of HBV and HBV vaccination coverage in health care workers of tertiary hospitals of Peshawar, Pakistan.

Authors:  Sobia Attaullah; Sanaullah Khan; Sultan Ayaz; Shahid Niaz Khan; Ijaz Ali; Naseruddin Hoti; Sami Siraj
Journal:  Virol J       Date:  2011-06-06       Impact factor: 4.099

5.  Molecular epidemiology of hcv among health care workers of khyber pakhtunkhwa.

Authors:  Sanaullah Khan; Sobia Attaullah; Sultan Ayaz; Shahid Niaz Khan; Sumaira Shams; Ijaz Ali; Muhammad Bilal; Sami Siraj
Journal:  Virol J       Date:  2011-03-08       Impact factor: 4.099

6.  Population-attributable estimates for risk factors associated with hepatitis B and C: policy implications for Pakistan and other South Asian countries.

Authors:  Bilal Ahmed; Tooba Ali; Huma Qureshi; Saeed Hamid
Journal:  Hepatol Int       Date:  2013-01-10       Impact factor: 6.047

7.  Co-treatment with pegylated interferon alfa-2a and entecavir for hepatitis D: A randomized trial.

Authors:  Zaigham Abbas; Mohammad Sadik Memon; Muhammad Amir Umer; Minaam Abbas; Lubna Shazi
Journal:  World J Hepatol       Date:  2016-05-18

Review 8.  Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data.

Authors:  Muhammad Umer; Mazhar Iqbal
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

9.  Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan: a modelling analysis.

Authors:  Aaron G Lim; Josephine G Walker; Nyashadzaishe Mafirakureva; Gul Ghuttai Khalid; Huma Qureshi; Hassan Mahmood; Adam Trickey; Hannah Fraser; Khawar Aslam; Gregoire Falq; Camille Fortas; Hassaan Zahid; Ammara Naveed; Rosa Auat; Quaid Saeed; Charlotte F Davies; Christinah Mukandavire; Nancy Glass; David Maman; Natasha K Martin; Matthew Hickman; Margaret T May; Saeed Hamid; Anne Loarec; Francisco Averhoff; Peter Vickerman
Journal:  Lancet Glob Health       Date:  2020-03       Impact factor: 26.763

10.  Hepatitis C Seroprevalence and Risk Factors in Adult Population of Chaharmahal and Bakhtiari Province of Iran in 2013.

Authors:  Masoumeh Moezzi; Reza Imani; Ali Karimi; Behrouz Pourheidar
Journal:  J Clin Diagn Res       Date:  2015-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.